Please login to the form below

Not currently logged in
Email:
Password:

Louise Tamblin returns to Kantar Health as group director

Moves from Strata Research

Kantar Health Louise TamblinLouise Tamblin has re-joined Kantar Health as group director after spending nearly two years as head of research at Strata Research.

Prior to her time at Strata, Tamblin spent eight years at Kantar Health and TNS Healthcare as group director, and before that worked with Intrepid Consultants and in academia.

Kantar Health's UK managing director Jim Needell said: “Louise re-joins us at an exciting time as Kantar Health UK expands its expert teams in market access and clinical trial research, as well as methodology and insight, to deliver excellence throughout the product lifecycle.

“We are delighted to welcome Louise back to our business as we continue to build our senior team.”

8th October 2012

From: PME

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics